Evidence map›Paper›PMID 33631926›Full record

ArticleTurkish journal of pharmaceutical sciences2021

Effect of

Issam Mohammed Abushammala, Fatma Khaled El-Shaikh Ali, Kamal Fakher Abu Shammaleh, Mohammed Mahmoud Taha, Mohammed Yousef Miqdad

Open access · diamondAbstract read
In one paragraph

Article in Turkish journal of pharmaceutical sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 49% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Issam Mohammed AbushammalaAl-Azhar University Faculty of Pharmacy, Department of Pharmaceutics and Industrial Pharmacy, Gaza Strip, Palestine.ORCID 0000-0002-3371-4718
Fatma Khaled El-Shaikh AliAl-Azhar University Faculty of Pharmacy, Department of Pharmaceutics and Industrial Pharmacy, Gaza Strip, Palestine.ORCID 0000-0003-0971-0802
Kamal Fakher Abu ShammalehAl-Azhar University Faculty of Pharmacy, Department of Pharmaceutics and Industrial Pharmacy, Gaza Strip, Palestine.ORCID 0000-0002-9476-7629
Mohammed Mahmoud TahaAl-Azhar University Faculty of Pharmacy, Department of Pharmaceutics and Industrial Pharmacy, Gaza Strip, Palestine.ORCID 0000-0001-9350-2111
Mohammed Yousef MiqdadAl-Azhar University-Gaza, College of Dentistry, Gaza Strip, Palestine.ORCID 0000-0002-6565-6225
Al-Azhar University – Gaza · PS

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesCarbamazepine (CBZ) is a well-known drug prescribed to treat epilepsy and the preferred drug for trigeminal neuralgia. This study was conducted to investigate the effect of MATERIALS AND

methodsAn

resultsCBZ had no significantly different pharmacokinetic (PK) parameters, namely, C

conclusionPGE may unlikely interfere with the PK of CBZ when it is co-administered with CBZ. Therefore, PGE can be used safely without precautions or dose monitoring.

Indexed as

CarbamazepineCYP3A4drug interactionPanax ginsengpharmacokinetics

Identifiers

PMID33631926
PMCPMC7957313
OpenAlexW2997744925

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.